Virtual Reality Cognitive Training for Brain Cancer Survivors

This study is looking at whether a virtual reality (VR) training program can help brain cancer survivors who have finished their treatment. The VR program, called VR-CRT, uses games to try and improve thinking skills (cognitive function), well-being, mental health, and quality of life. Some participants will use the VR system, while others will do word search puzzles. The study wants to see if at least 80% of participants can complete the VR program over 4 weeks, and if they find it acceptable. It also measures changes in thinking skills. You might be able to join if you are an adult (18 or older) who has survived a low-grade glioma (a type of brain cancer), have mild cognitive impairment (MCI), and finished all your cancer treatments between 30 days and 24 months ago. The study aims to enroll 40 participants, but its current recruitment status is unclear.

Study design
This is an interventional study planning to enroll 40 participants. Participants will be randomized to either use a Virtual Reality System or complete Word Search Puzzles.
What's involved
Participants will use either the VR system or word search puzzles for 4 weeks. Thinking skills will be measured at the beginning and after the 4-week intervention.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for 4 weeks, with measurements taken at the end of this period.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07313709

Measuring the Feasibility and Effect of a Virtual Reality Cognitive Training Intervention for Brain Cancer Survivors.

Not Yet Recruiting
NAAges 18+InterventionalSupportive care
University of Cincinnati
~40 participants
Updated 2026-01-02 on ClinicalTrials.gov
What's tested:Virtual Reality SystemWord Search Puzzles

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Feasibility defined as >80% (> 16 participants out of 20) able to complete the experimental arm study in 4 weeks.
Measured over 4 weeks
+4 more outcomes measured
Brain Cancer

NCT07313709

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • University of Cincinnati Medical Center

    Cincinnati, Ohiostudy coordinator listed

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Exclusion

1\. History of serious mental or severe psychiatric illnesses (e.g., bi-polar disorder, schizophrenia etc....).
  • Feasibility defined as >80% (> 16 participants out of 20) able to complete the experimental arm study in 4 weeks.4 weeks

    FEASIBILITY: Measure the feasibility of using VR-CRT and Control (i.e., paper-based Word-search puzzles (WSP)) with brain cancer survivors (BCS) experiencing cancer-related cognitive impairment (CRCI). Feasibility: will be defined as \>80% (\> 16 participants out of 20) able to complete the experimental arm study in 4 weeks. Since the standard/control arm is well established and routine, feasibility evaluation is not required in this arm. (If subjects withdraw in disproportion in two arms after the randomization, the study may be suspended for further evaluation.)

  • Acceptability defined as scores of >8 on each subscale of the Senior Technology Acceptance Model (STAM).54 The STAM (Short Version) measures four attitudes towards technology on a Likert scale of 1-10.4 weeks

    ACCEPTABILITY: Measure the acceptability of using VR-CRT and Control (i.e., paper-based Word-search puzzles (WSP)) with brain cancer survivors (BCS) experiencing cancer-related cognitive impairment (CRCI). Acceptability: will be defined as scores of \>8 on each subscale of the Senior Technology Acceptance Model (STAM).54 The STAM (Short Version) measures four attitudes towards technology on a Likert scale of 1-10. (See sections 3.1, 17.1 for detail.) This score of \>8 for all 14 responses will be calculated as an average of all of the completed sub-scales per each subject. Any missing sub-scales (non-response by subjects) will not be considered into the calculation of the mean per subject. The score of \>8 must be observed in \>80% (\>32 participants) to be considered acceptable.

  • Effect of VR-CRT (and Control) on cognitive function measured by scores at baseline and post-intervention,using 1.) Hopkins Verbal Learning Test4 weeks

    EFFECT: Estimate the effect of VR-CRT (and Control) on brain cancer survivors' cognitive function such as memory, attention/focus, processing speed, and executive function. Effect: will be measured by 1.) Hopkins Verbal Learning Test (HVLT)

  • Effect of VR-CRT (and Control) on cognitive function measured by scores at baseline and post-intervention,using 2.) Controlled Oral Word Association4 weeks

    EFFECT: Estimate the effect of VR-CRT (and Control) on brain cancer survivors' cognitive function such as memory, attention/focus, processing speed, and executive function. Effect: will be measured by comparing scores collected at baseline and post-intervention, (i.e., at the conclusion of a four-week intervention period) using 2.) Controlled Oral Word Association (COWA)

  • Effect of VR-CRT (and Control) on cognitive function measured by scores at baseline and post-intervention,using 3.) Trail Making A-B4 weeks

    EFFECT: Estimate the effect of VR-CRT (and Control) on brain cancer survivors' cognitive function such as memory, attention/focus, processing speed, and executive function. Effect: will be measured by comparing scores collected at baseline and post-intervention, (i.e., at the conclusion of a four-week intervention period) using 3.) Trail Making A-B (TMa/b).